TNFSF11 and osteoporosis: A previous study shows that immunisation with mutant RANKL molecules generates anti-RANKL antibodies that block the interaction between RANKL and its receptor in an animal model of osteoporosis, thereby preventing proliferation and differentiation of osteoclasts and improving bone density45.